DETHEUX MICHEL (Chief Executive Officer) received a stock award from ITEOS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/11/2025ACC: 0000950170-25-037515
DirectorOfficer· Chief Executive Officer
Since Jul 2020
+536K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
536K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+77K
Price / share
—
Trade value
—
% of position
130.7%
3/7/2025
58.90K→135.90K
Total
Net shares
+77K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/7/2025 | A · Award | +77K | — | — | 130.7% | 58.90K | 135.90K |
| Total | +77K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
459K shares
Shares
+459K
Strike price
7.05
Held after
459K
Exercisable
—
3/7/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock459K shares | 3/7/2025 | A · Award | +459K | 7.05 | — | 459K |